Volume Doubling Times of Lung Adenocarcinomas: Correlation with Predominant Histologic Subtypes and Prognosis

医学 四分位间距 比例危险模型 腺癌 倍增时间 病理 回顾性队列研究 肺癌 放射科 核医学 内科学 癌症 细胞 遗传学 生物
作者
Sohee Park,Sang Min Lee,Seon‐Ok Kim,June‐Goo Lee,Sehoon Choi,Kyung‐Hyun Do,Joon Beom Seo
出处
期刊:Radiology [Radiological Society of North America]
卷期号:295 (3): 703-712 被引量:47
标识
DOI:10.1148/radiol.2020191835
摘要

Background The volume doubling time (VDT) is a key parameter in the differentiation of aggressive tumors from slow-growing tumors. How different histologic subtypes of primary lung adenocarcinomas vary in their VDT and the prognostic value of this measurement is unknown. Purpose To investigate differences in VDT between the predominant histologic subtypes of primary lung adenocarcinomas and to assess the correlation between VDT and prognosis. Materials and Methods This retrospective study included patients who underwent at least two serial CT examinations before undergoing operation between July 2010 and December 2018. Three-dimensional tumor segmentation was performed on two CT images and VDTs were calculated. VDTs were compared between predominant histologic subtypes and lesion types by using Kruskal-Wallis tests. Disease-free survival (DFS) was obtained in patients undergoing surgical procedures before July 2017. Univariable and multivariable Cox proportional hazards regression analyses were performed to determine predictors of DFS. Results Among 268 patients (mean age, 64 years ± 8 [standard deviation]; 143 men), there were 30 lepidic, 87 acinar, 109 papillary, and 42 solid or micropapillary predominant subtypes. The median VDT was 529 days (interquartile range, 278–872 days) for lung adenocarcinomas. VDTs differed across subtypes (P < .001) and were shortest in solid or micropapillary subtypes (229 days; interquartile range, 77–530 days). Solid lesions (VDT, 248 days) had shorter VDTs than subsolid lesions (part-solid lesions, 665 days; nonsolid lesions, 648 days) (P < .001). In the 148 patients (mean age, 64 years ± 8; 89 men) included in the survival analysis, 35 patients had disease recurrence and 17 patients died. VDT (<400 days) was an independent risk factor for poor DFS (hazard ratio, 2.6; P = .01) and higher TNM stage. Adding VDT to TNM stage improved model performance (C-index, 0.69 for TNM stage vs 0.77 for combined VDT class and TNM stage; P = .002). Conclusion Volume doubling times varied significantly according to the predominant histologic subtypes of lung adenocarcinoma and had additional prognostic value for disease-free survival. © RSNA, 2020 Online supplemental material is available for this article. See also the editorial by Ko in this issue.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
彭于晏应助潘潘采纳,获得10
3秒前
SYLH应助糊涂的寒蕾采纳,获得20
4秒前
星辰大海应助hudiefeifei306采纳,获得10
4秒前
王小白发布了新的文献求助10
4秒前
科研通AI5应助冯习采纳,获得10
8秒前
蓝莓酥study完成签到,获得积分10
8秒前
HEIKU举报海洋求助涉嫌违规
11秒前
王小白完成签到,获得积分10
11秒前
11秒前
14秒前
NexusExplorer应助我不是阿呆采纳,获得10
16秒前
17秒前
HongqiZhang完成签到 ,获得积分10
18秒前
潘潘发布了新的文献求助10
18秒前
ll发布了新的文献求助10
18秒前
聪明的惜芹完成签到,获得积分10
19秒前
19秒前
Yue完成签到 ,获得积分10
19秒前
3AM发布了新的文献求助10
21秒前
矢车菊完成签到 ,获得积分10
22秒前
有魅力的电脑完成签到 ,获得积分10
23秒前
船夫发布了新的文献求助30
23秒前
轻松小张发布了新的文献求助10
24秒前
科研通AI5应助Shirley采纳,获得10
25秒前
28秒前
29秒前
30秒前
WW完成签到,获得积分20
31秒前
32秒前
32秒前
船夫完成签到,获得积分10
34秒前
科研通AI5应助轻松小张采纳,获得10
34秒前
LeezZZZ发布了新的文献求助10
34秒前
34秒前
zhiyu发布了新的文献求助10
36秒前
陆拾荒完成签到,获得积分10
38秒前
善良的沛山完成签到,获得积分10
38秒前
39秒前
40秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
China—Art—Modernity: A Critical Introduction to Chinese Visual Expression from the Beginning of the Twentieth Century to the Present Day 360
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3776925
求助须知:如何正确求助?哪些是违规求助? 3322345
关于积分的说明 10209855
捐赠科研通 3037696
什么是DOI,文献DOI怎么找? 1666837
邀请新用户注册赠送积分活动 797658
科研通“疑难数据库(出版商)”最低求助积分说明 758001